CAPR
Capricor Therapeutics Inc
8.60$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.3% | +7.7% | +7.7% | +1.2% | +4.0% | +7.9% | +19.9% | +50,639.5% | +306.7% | -99.9% | +55,239.9% | – | |
| – | +8.4% | +75.4% | -34.1% | -4.7% | +11.9% | +150.0% | -36.5% | +201,945.8% | -146.1% | – | +161,743.2% | – | |
| – | – | – | -176.7% | – | – | – | -85.7% | -99.7% | -20,548.2% | – | – | – | |
| – | +15.4% | -8.9% | -87.8% | -27.0% | +1,144.7% | +55.2% | +27.1% | +176.6% | +27.8% | +109.7% | -45.1% | – | |
| – | -175.9% | +62.1% | – | -86.4% | -6,254.8% | – | -39.1% | +9.6% | +170.1% | -458.9% | -68.5% | – | |
| – | +10,378.9% | -90.1% | -9.7% | +3,157.1% | +20.4% | -99.9% | -61.1% | -64.5% | +3,579,977.9% | -99.4% | -388.5% | – | |
| – | – | -248.5% | – | +1,189.5% | -199.0% | – | -131.7% | – | – | -168.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.